經腸營養市場：依產品、流型、階段、適應症、最終用途、銷售管道及地區分類

預計到2026年，經腸營養市場規模將達到76.1億美元，到2033年將達到145.6億美元。預計從2026年到2033年，其複合年成長率將達到9.7%。

經腸營養是將營養補充品直接注入胃、十二指腸或空腸，供無法經口攝取足夠營養的個體使用。經腸營養種類繁多。蛋白質配方主要成分為蛋白質，適用於需要營養支持或需要減少碳水化合物和脂肪攝取的個體。標準配方含有均衡的碳水化合物、蛋白質和脂肪，能夠滿足多數人的日常營養需求，適合長期使用。疾病特異性配方則針對特定的健康狀況，例如糖尿病、腎衰竭和肝病。含纖維配方提供可溶性和不可溶性纖維，以促進正常的腸道功能。

每種營養補充劑都有其自身的優缺點。蛋白質補充劑有助於在不攝取過多熱量的情況下滿足蛋白質需求，但營養均衡性較差。標準補充劑提供均衡的營養，但可能無法滿足特定的飲食需求。疾病特異性補充劑針對特定疾病的營養需求，但價格較高。含纖維配方有助於規律排便，但質地黏稠，熱量較高。應根據個人的健康狀況、營養需求和耐受性選擇合適的配方。經腸營養可確保無法透過口服攝取營養的患者獲得充足的營養。

市場動態

全球經腸營養市場正受到人口老化、慢性病發病率上升、早產兒增加以及成人吞嚥困難病例激增等因素的推動。聯合國預測，到2050年，60歲及以上人口預計將增加近一倍，超過年輕人口。老年人更容易患上需要經腸營養支持的疾病，例如失智症和術後併發症。此外，癌症、神經系統疾病和胃腸道疾病等慢性病在全球範圍內不斷增加，導致對經腸營養支持的需求日益成長。這些因素對市場成長產生了正面影響。然而，其他營養攝取方式的存在、導管相關的感染風險以及特殊營養補充劑的高成本正在限制市場成長。有機、非基因改造和無過敏原營養補充劑的開發為市場相關人員帶來了巨大的商機。

本次調查的主要特點

• 本研究確定了各細分市場的潛在收入成長機會，並說明了該市場具有吸引力的投資提案矩陣。
• 此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
• 本研究根據以下參數對全球經腸營養市場的主要參與者進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。
• 透過利用本報告中的見解，企業負責人和經營團隊將能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
• 全球經腸營養市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
• 相關人員可以透過利用全球經腸營養市場分析中使用的各種策略矩陣來簡化決策過程。

目錄

第1章：研究目標與前提條件

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

• 市場動態
  • 慢性病發生率增加
  • 醫療保健環境和報銷政策的變化
  • 居家照護服務的需求日益成長
• 影響分析
• 主要亮點
• 監管趨勢
• 服務提供組合
• PEST分析
• 波特的分析
• 併購情景
• 管道分析

第4章 全球經腸營養市場：依產品分類，2021-2033年

• 標準營養補充品
• 針對特定疾病的營養補充品
• 營養補充品
• 特殊營養補充品

第5章 全球經腸營養市場：以輸注方式分類，2021-2033年

• 間歇性餵食流
• 連續進料流

第6章 全球經腸營養市場：依階段分類，2021-2033年

• 成人
• 兒童

第7章 全球經腸營養市場：依適應症分類，2021-2033年

• 阿茲海默症
• 營養缺乏
• 癌症治療
• 糖尿病
• 慢性腎臟病
• 罕見疾病
• 吞嚥困難
• 疼痛管理
• 其他（吸收不良/消化系統疾病/腹瀉等）

第8章 全球經腸營養市場：依最終用戶分類，2021-2033年

• 醫院
• 居家照護

第9章 全球經腸營養市場：依銷售管道，2021-2033年

• 線上銷售
• 零售
• 向機構銷售

第10章 全球經腸營養市場：依地區分類，2021-2033年

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太國家
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲國家
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東國家
• 非洲
  • 北非
  • 中非
  • 南非

第11章 競爭格局

• Nestle
• VICTUS
• Primus Pharmaceuticals, Inc.
• Meiji Holdings. Co., Ltd.
• Mead Johnson & Company, LLC
• Abbott
• Danone SA
• Fresenius Kabi AG

第12章

• 調查方法
• 關於本公司

Enteral Feeding Formulas Market is estimated to be valued at USD 7.61 Bn in 2026 and is expected to reach USD 14.56 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.7%USD 14.56 Bn from 2026 to 2033.

Enteral feeding formulas are nutritional supplements that are administered directly into the stomach, duodenum, or jejunum of individuals who cannot obtain adequate oral intake. There are different types of enteral feeding formulas available. Protein-based formulas contain protein as the main nutrient and are used for individuals who need nutrition support but minimal carbohydrate or fat intake. Standard formulas provide a balanced proportion of carbohydrates, proteins, and fats. They meet most daily nutritional needs and are suitable for long-term use. Disease-specific formulas are tailored for certain health conditions like diabetes, renal failure, or liver disease. Fiber-containing formulas provide soluble and insoluble fiber to promote normal bowel function.

Each type of formula has its own advantages and disadvantages. Protein-based formulas help meet protein needs without excess calories but lack balanced nutrition. Standard formulas provide balanced nutrition but may not meet special dietary needs. Disease-specific formulas address the unique nutritional requirements of certain illnesses but come at a higher cost. Fiber-containing formulas aid in regular bowel movements but have a thicker consistency and higher calorie content. The appropriate formula must be selected based on the individual's health status, nutritional requirements, and tolerateability. Enteral feeding ensures adequate nutrition in patients who cannot obtain nutrition through oral intake.

Market Dynamics

The global enteral feeding formulas market is driven by the rising geriatric population, increasing incidence of chronic diseases, growing number of preterm births, and surging cases of dysphagia among adults. As per UN projections, the population aged 60 years and above will nearly double by 2050 and become larger than the youth population. The aged people is more prone to conditions requiring enteral feeding assistance like dementia and complications post-surgery. Additionally, chronic diseases like cancer, neurological disorders, and gastrointestinal illnesses, necessitating enteral nutrition aids are on the rise internationally. This is positively impacting the market growth. However, the availability of alternative delivery methods, risk of infections associated with tubes, and high costs of specialized formulas are restraining the market growth. The development of organic, non-GMO (non-genetically modified organisms), and allergen-free formulas presents lucrative opportunities for market players.

Key Features of the Study

• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global enteral feeding formulas market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Nestle, VICTUS, Primus Pharmaceuticals, Inc., Meiji Holdings. Co., Ltd., Mead Johnson & Company, LLC, Abbott, Danone S.A, and Fresenius Kabi AG.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global enteral feeding formulas market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global enteral feeding formulas market.

Market Segmentation

• By Product (Revenue, USD Bn, 2021 - 2033)
• Standard Formula
• Disease-specific Formulas
• Elemental Formulas
• Specialized Formulas
• By Flow Type (Revenue, USD Bn, 2021 - 2033)
• Intermittent Feeding Flow
• Continuous Feeding Flow
• By Stage (Revenue, USD Bn, 2021 - 2033)
• Adults
• Pediatrics
• By Indication (Revenue, USD Bn, 2021 - 2033)
• Alzheimer's
• Nutrition Deficiency
• Cancer Care
• Diabetes
• Chronic Kidney Diseases
• Orphan Diseases
• Dysphagia
• Pain Management
• Others (Malabsorption/GI Disorder/Diarrhea, etc.)
• By End Use (Revenue, USD Bn, 2021 - 2033)
• Hospitals
  • Cardiology
  • Neurology
  • Critical Care (ICU)
  • Oncology
  • Others
• Home Care
• By Sales Channel (Revenue, USD Bn, 2021 - 2033)
• Online Sales
• Retail Sales
• Institutional Sales
• By Region (Revenue, USD Bn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Companies
• Nestle
• VICTUS
• Primus Pharmaceuticals, Inc.
• Meiji Holdings. Co., Ltd.
• Mead Johnson & Company, LLC
• Abbott
• Danone S.A
• Fresenius Kabi AG

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Enteral Feeding Formulas Market, By Product
  • Global Enteral Feeding Formulas Market, By Flow Type
  • Global Enteral Feeding Formulas Market, By Stage
  • Global Enteral Feeding Formulas Market, By Indication
  • Global Enteral Feeding Formulas Market, By End User
  • Global Enteral Feeding Formulas Market, By Sales Channel
  • Global Enteral Feeding Formulas Market, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Rising incidence of chronic diseases
  • Changes in healthcare landscape and reimbursement policies
  • Increasing preference for homecare services
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Service offering Portfolio
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Pipeline Analysis

4. Global Enteral Feeding Formulas Market, By Product, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Standard Formula
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
• Disease-specific Formulas
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
• Elemental Formulas
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
• Specialized Formulas
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)

5. Global Enteral Feeding Formulas Market, By Flow Type, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Intermittent Feeding Flow
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
• Continuous Feeding Flow
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)

6. Global Enteral Feeding Formulas Market, By Stage, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Adults
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
• Pediatrics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)

7. Global Enteral Feeding Formulas Market, By Indication, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Alzheimer's
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
• Nutrition Deficiency
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
• Cancer Care
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
• Diabetes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
• Chronic Kidney Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
• Orphan Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
• Dysphagia
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
• Pain Management
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
• Others (Malabsorption/GI Disorder/Diarrhea, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)

8. Global Enteral Feeding Formulas Market, By End User, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
    • Cardiology
    • Neurology
    • Critical Care (ICU)
    • Oncology
    • Others
• Home Care
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)

9. Global Enteral Feeding Formulas Market, By Sales Channel, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Online Sales
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
• Retail Sales
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)
• Institutional Sales
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(USD Bn)

10. Global Enteral Feeding Formulas Market, By Region, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, For Region, 2021 - 2033
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Flow Type, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Stage, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Flow Type, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Stage, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Flow Type, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Stage, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Flow Type, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Stage, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Flow Type, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Stage, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Flow Type, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Stage, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2021 - 2033,(USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2021 - 2033,(USD Bn)
    • North Africa
    • Central Africa
    • South Africa

11. Competitive Landscape

• Nestle
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• VICTUS
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Primus Pharmaceuticals, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Meiji Holdings. Co., Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Mead Johnson & Company, LLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Abbott
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Danone S.A
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Fresenius Kabi AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

12. Section

• Research Methodology
• About us